Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | L-Homoserine | HCID 12647 | — |
| Reactant | HCID 71183343 | HCID 71183343 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Product | HCID 71183365 | HCID 71183365 | 10.8% |
Reaction Steps
1-Methyl-6-(4-(trifluoromethoxy)phenyl)-1H-benzo[d][1,3]oxazine-2,4-dione (60 mg, 0.178 mmol) and L-homoserine (23.3 mg, 0.196 mmol, 1.1 equiv.) were added to a magnetically stirred 0.5-2 mL Smith process vial containing 0.75 mL glacial acetic acid. Reaction mixture was then heated for 2 hours at 130° C. Excess acetic acid was then removed en vacuo, residue was dissolved into a minimal amount of acetonitrile and purified by reverse-phase preparative HPLC to give the title compound (7.6 mg) following removal of solvent as a clear yellow film.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09193694B2 |
|---|
| Source dataset | uspto-grants-2015_11 |
|---|
| ORD ID | ord-326b95aa29d64866b0bcbff72c41ad3d |
|---|
| Source note | uspto-grants-2015_11 |
|---|